Relay Therapeutics (RLAY)

• Market cap: $2.43B
• 1 day: -1.85%
• 5 days: -14.4%
• 1 month: 18.11%
• 3 months: 56.07%
• 6 months: 83.29%
• Year to date: 55.5%
• 1 year: 286.63%
• 5 years: -59.9%
• 10 years: -63.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Employees: 192